Curving Tuberculosis: Current Trends and Future Needs.

Area of Science:

• Public Health
• Infectious Diseases
• Microbiology

Background:

• Tuberculosis (TB) remains a significant global health challenge, exacerbated by Human Immunodeficiency Virus (HIV) co-infection and the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Mycobacterium tuberculosis strains.
• The World Health Assembly has set ambitious targets to reduce TB deaths and incidence by 95% by 2035, necessitating innovative approaches.

Purpose of the Study:

• To outline essential new strategies required to meet global tuberculosis control targets.
• To emphasize the need for advancements in diagnostics, vaccines, and treatment regimens for all forms of TB, especially drug-resistant cases.

Main Methods:

• The abstract discusses the necessity of active case-finding in high-risk populations.
• It highlights the importance of developing accurate point-of-care diagnostic tests and rapid drug resistance detection methods.
• The need for novel vaccines and new prophylactic and treatment regimens, particularly for MDR and XDR TB, is emphasized.

Main Results:

• The abstract does not present specific results but outlines a strategic direction for TB control.
• It underscores the critical need for highly effective drug regimens capable of achieving high cure rates irrespective of Mycobacterium tuberculosis resistance patterns.

Conclusions:

• Achieving global tuberculosis control targets by 2035 requires a multifaceted approach incorporating enhanced case ascertainment, diagnostics, and innovative therapeutic strategies.
• The development of universally effective treatments is paramount to overcoming challenges posed by drug-resistant TB strains and co-infections like HIV.